|
⚲
|
| Keyboard |
| Almon Einat Brill
✚
|
|
|---|---|
| CIK # | 0001385116 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001385116] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Protalix BioTherapeutics Inc | |
| Almon Einat Brill |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2020-06-07 | Grant | 196,995 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2018-09-13 | Grant | 700,000 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2015-03-23 | Grant | 250,000 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2012-07-16 | Grant | 185,000 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2012-05-02 | Option exercise | 50,000 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2012-05-02 | Sell | 166,848 | $7.13 | 1,189,626 |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2012-05-02 | Option exercise | 116,848 | $0.97 | 113,343 |
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2012-05-02 | Option exercise | 116,848 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2012-05-02 | Option exercise | 50,000 | $2.65 | 132,500 |